Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating -Omic Features and Prognostic Indicators of Cervical Spondylotic Myelopathy

NCT07772297 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT07772297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07772297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating -Omic Features and Prognostic Indicators of Cervical Spondylotic Myelopathy
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
September 30, 2030
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical spondylotic myelopathy